HOME >> MEDICINE >> NEWS
Different type of iron supplement is better at boosting iron levels

Fortifying cereals with a different type of iron supplement reduces anaemia, iron-deficiency anaemia and general iron deficiency children in developing countries, and boosts three major iron status indicators, conclude authors of an Article published in this weeks edition of The Lancet.

Sodium Iron EDTA (NaFeEDTA) was found to be much more effective than electrolytic iron, despite the electrolytic form being the most frequently used iron supplement in flour.

Pauline Andango, Kenya Medical Research Institute, Centre for Public Health Research, Nairobi, Kenya and Netherlands-based colleagues studied 516 children aged three to eight years from four schools in Marafa, Kenya, some 10% of whom were suffering from anaemia.

Anaemia is defined as a shortage of red blood cells and/or haemoglobin (the oxygen-carrying iron complex) in the blood one cause of which is iron deficiency.

The authors say: "Fortification of staple cereal flours could be a cost-effective, sustainable way to improve iron status in developing countries."

The children in the study were divided into four groups and each given the same amount of porridge daily, five times a week. The placebo group had porridge made with unfortified whole maize flour. For the other three groups the porridge was fortified with either high-dose NaFeEDTA (56mg/kg), low-dose NaFeEDTA (28mg/kg) or electrolytic iron (56mg/kg).

The researchers found that, compared to the placebo group, the prevalence of iron-deficiency anaemia dropped by 89% for the high-dose NaFeEDTA group, and by 48% for the low-dose NaFeEDTA group, but there was no evidence for any reduction in the electrolytic iron group.

High-dose NaFeEDTA fortified flour also improved three major iron status indicators in the children taking flour fortified with it haemoglobin and plasma ferritin concentrations, and amounts of plasma soluble transferrin receptor. Low-dose NaFeEDTA also improved these
'"/>

Contact: Pauline Andango
pauline.andango@wur.nl
31-620-815-357
Lancet
24-May-2007


Page: 1 2

Related medicine news :

1. Different gene-expression predictors of breast cancer agree, UNC study shows
2. Different options produce similar results
3. Different forms of amyloid beta in Alzheimers disease harm neurons in different ways
4. Different consultants mean different lengths of stay in hospitals
5. Differential heart-attack risks among blacks, whites remain mystery
6. Different antipsychotic medications may have different effects on brain volume
7. Sucampo Pharmaceuticals submits supplemental new drug application for Lubiprostone to treat IBS-C
8. Folic acid supplements do not appear to reduce risk of colorectal tumors
9. Folic acid supplementation lowers stroke risk
10. Some vitamin supplements dont protect against lung cancer
11. Vitamin D supplements may offer cheap and effective immune system boost against TB

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Different type iron supplement better boosting iron levels

(Date:5/21/2013)... Boston, Mass.By studying the roles two proteins, thrombospondin-1 ... trans-Atlantic research team has identified a five-amino acid ... in mouse models of prostate, breast and lung ... could potentially block metastasis in a variety of ... Randolph Watnick, PhD, at Boston Children,s Hospital, Vivek ...
(Date:5/21/2013)... May 21, 2013 The nation’s first ... is nearing its conclusion in Washington state court, ... closing statements yesterday, an attorney for the Plaintiffs compared ... wanted to tie sales and services for its customers. ... to keep control of surgeons, to keep control of ...
(Date:5/21/2013)... A new study appearing in the ... stem cells harvested from fat (adipose) are more potent ... modulate the body’s immune system. , The finding ... as adipose tissue-derived stem cells (AT-SCs) are far more ... marrow and can be collected from waste material from ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Less is more ... severe bouts of chronic obstructive pulmonary disease (COPD), according ... with prednisone to treat COPD flare-ups was as good ... for adverse side effects, they said. "We wanted ... not less effective than 14 days," said lead researcher ...
(Date:5/21/2013)... of Iowa,s vice president for research and economic ... computing, the next generation of supercomputers designed to ... the human mind. , Daniel Reed will appear ... the House Subcommittee on Energy, titled, "America,s Next ... at 10 a.m. in Room 2318 of the ...
Breaking Medicine News(10 mins):Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3Health News:Iowa VP for Research addresses next-generation supercomputers at congressional hearing 2
(Date:5/21/2013)... May 21, 2013 On its tenth ... product developments at the Special Libraries Association PHTD meeting in ... focus on product literature databases and workflow solutions for the ... said founding director Nigel Johnson . "At ... to our clients and what better forum to announce them ...
(Date:5/21/2013)... 21, 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show ... the greatest number of "Emerging" small molecule biotech ... Mark Alexay .  "No one saw this ... year.  The show,s still 4 months away and we ... a big surprise and great news for attendees". Thecurrent ...
(Date:5/21/2013)... 2013  Decision Resources, one of the ... pharmaceutical and healthcare issues, finds that the ... efficacy endpoints, including overall survival and time ... over surveyed U.S. and European oncologists, prescribing ... breast cancer. The two novel emerging therapies ...
Breaking Medicine Technology:Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
Cached News: